The new Instituto Bernabeu Group newsletter is now available, dedicated to our last achievements on research & development.
The Ministry of Economy and Competitiveness has awarded Instituto Bernabeu the title of Innovative Company which is given to companies with a proven track record in innovation and in their ability to be innovative in R&D work.
For over three decades, morphological analysis has been the most efficient and most used manner of studying embryo quality. Nowadays, Comprehensive Chromosomal Screening (CCS) is also possible and this enables all embryo chromosomes to be studied. Some research appears to demonstrate that embryo classification based on morphological criteria may change by selecting embryos which are apt for transfer amongst those which have undergone CCS analysis. In our research, we aimed to provide more concrete data on which parameters of embryo morphology might have prognosis qualities following CCS.
The use of comprehensive chromosome screening (CCS) during the blastocyst stage has led to big changes in in vitro fertilisation (IVF) clinics. The transfer of fresh embryos is generally put on hold for one day until the results of chromosomal diagnosis are available. This means that many of the blastocysts have already hatched and have to be transferred or undergo vitrification on day 6 of development.
Thank you for your interest in our institution. We will contact you soon to confirm your request.
If you prefer to contact us by phone, please call:
+34 965 50 40 00